Answer
The saponin-based Matrix-M adjuvant in Nuvaxovid JN.1 facilitates activation of innate immune cells, enhancing the magnitude of the spike protein-specific immune response.
Sources for this answer
- Nuvaxovid JN.1 dispersion for injection in pre-filled syringeSANOFI · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked